Literature DB >> 20156888

Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating.

J Lou1, I Geren, C Garcia-Rodriguez, C M Forsyth, W Wen, K Knopp, J Brown, T Smith, L A Smith, J D Marks.   

Abstract

Botulism is caused by the botulinum neurotoxins (BoNTs), the most poisonous substance known. Because of the high potency of BoNT, development of diagnostic and therapeutic antibodies for botulism requires antibodies of very high affinity. Here we report the use of yeast mating to affinity mature BoNT antibodies by light chain shuffling. A library of immunoglobulin light chains was generated in a yeast vector where the light chain is secreted. The heavy chain variable region and the first domain of the constant region (V(H)-C(H)1) from a monoclonal antibody was cloned into a different yeast vector for surface display as a fusion to the Aga2 protein. Through yeast mating of the two haploid yeasts, a library of light chain-shuffled Fab was created. Using this approach, the affinities of one BoNT/A and two BoNT/B scFv antibody fragments were increased from 9- to more than 77-fold. Subcloning the V-genes from the affinity-matured Fab yielded fully human IgG1 with equilibrium binding constants for BoNT/A and BoNT/B of 2.51 x 10(-11) M or lower for all three monoclonal antibodies. This technique provides a rapid route to antibody affinity maturation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156888      PMCID: PMC2841544          DOI: 10.1093/protein/gzq001

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  29 in total

1.  Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.

Authors:  Peter Amersdorfer; Cindy Wong; Theresa Smith; Steven Chen; Sharad Deshpande; Robert Sheridan; James D Marks
Journal:  Vaccine       Date:  2002-02-22       Impact factor: 3.641

Review 2.  Antibodies from phage antibody libraries.

Authors:  Andrew R M Bradbury; James D Marks
Journal:  J Immunol Methods       Date:  2004-07       Impact factor: 2.303

3.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Generation of a panel of related human scFv antibodies with high affinities for human CEA.

Authors:  J K Osbourn; A Field; J Wilton; E Derbyshire; J C Earnshaw; P T Jones; D Allen; J McCafferty
Journal:  Immunotechnology       Date:  1996-09

5.  CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range.

Authors:  W P Yang; K Green; S Pinz-Sweeney; A T Briones; D R Burton; C F Barbas
Journal:  J Mol Biol       Date:  1995-12-01       Impact factor: 5.469

6.  Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.

Authors:  R Schier; J Bye; G Apell; A McCall; G P Adams; M Malmqvist; L M Weiner; J D Marks
Journal:  J Mol Biol       Date:  1996-01-12       Impact factor: 5.469

Review 7.  Bacterial toxins: a table of lethal amounts.

Authors:  D M Gill
Journal:  Microbiol Rev       Date:  1982-03

8.  Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries.

Authors:  P Amersdorfer; C Wong; S Chen; T Smith; S Deshpande; R Sheridan; R Finnern; J D Marks
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

9.  Construction and diversification of yeast cell surface displayed libraries by yeast mating: application to the affinity maturation of Fab antibody fragments.

Authors:  Lydia Blaise; Anita Wehnert; Mieke P G Steukers; Twan van den Beucken; Hennie R Hoogenboom; Simon E Hufton
Journal:  Gene       Date:  2004-11-24       Impact factor: 3.688

10.  Selection of phage antibodies by binding affinity. Mimicking affinity maturation.

Authors:  R E Hawkins; S J Russell; G Winter
Journal:  J Mol Biol       Date:  1992-08-05       Impact factor: 5.469

View more
  23 in total

Review 1.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

Review 2.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

3.  Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein.

Authors:  Q Meng; M Li; M A Silberg; F Conrad; J Bettencourt; R To; C Huang; J Ma; K Meyer; R Shimizu; L Cao; M T Tomic; J D Marks
Journal:  Anal Biochem       Date:  2011-10-06       Impact factor: 3.365

4.  Fab is the most efficient format to express functional antibodies by yeast surface display.

Authors:  Coline Sivelle; Raphaël Sierocki; Kelly Ferreira-Pinto; Stéphanie Simon; Bernard Maillere; Hervé Nozach
Journal:  MAbs       Date:  2018-05-24       Impact factor: 5.857

Review 5.  Antibodies for biodefense.

Authors:  Jeffrey W Froude; Bradley Stiles; Thibaut Pelat; Philippe Thullier
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

6.  Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays.

Authors:  Yanfeng Zhang; Jianlong Lou; Kathy L Jenko; James D Marks; Susan M Varnum
Journal:  Anal Biochem       Date:  2012-08-27       Impact factor: 3.365

7.  Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.

Authors:  C Garcia-Rodriguez; I N Geren; J Lou; F Conrad; C Forsyth; W Wen; S Chakraborti; H Zao; G Manzanarez; T J Smith; J Brown; W H Tepp; N Liu; S Wijesuriya; M T Tomic; E A Johnson; L A Smith; J D Marks
Journal:  Protein Eng Des Sel       Date:  2010-12-13       Impact factor: 1.650

8.  Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.

Authors:  Q Meng; C Garcia-Rodriguez; G Manzanarez; M A Silberg; F Conrad; J Bettencourt; X Pan; T Breece; R To; M Li; D Lee; L Thorner; M T Tomic; J D Marks
Journal:  Anal Biochem       Date:  2012-08-21       Impact factor: 3.365

9.  Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.

Authors:  Suzanne R Kalb; Consuelo Garcia-Rodriguez; Jianlong Lou; Jakub Baudys; Theresa J Smith; James D Marks; Leonard A Smith; James L Pirkle; John R Barr
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

10.  Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture.

Authors:  Jan P Bogen; Stefania C Carrara; David Fiebig; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.